Ganymede

Ganymede

软件开发

Palo Alto,California 9,424 位关注者

Ganymede is the modern cloud data platform for the life sciences and manufacturing.

关于我们

Ganymede liberates your data by connecting your instruments, your LIMS, and your databases into one FAIR data layer. Stop dealing with files and data entry. Our Lab-as-Code technology powers data automation, saving scientists up to 20% of their time, and providing rich data for compliance and AI/ML.

网站
https://ganymede.bio/
所属行业
软件开发
规模
11-50 人
总部
Palo Alto,California
类型
私人持股
创立
2022

地点

  • 主要

    3000 El Camino Real

    Bldg. 4, Suite 200

    US,California,Palo Alto,94306

    获取路线

Ganymede员工

动态

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    Ganymede's Asset Utilization and Reliability Analysis (Aura) data product streamlines lab operations by centralizing data from diverse instruments and systems. It provides analytics to track performance, identify bottlenecks, and optimize workflows. With error diagnostics and predictive maintenance, Aura minimizes downtime and supports overnight runs. The platform enhances cost efficiency and capacity planning while laying the groundwork for AI-driven insights.

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    ?? Wrapping up an amazing 2024 with our community! ?? As the year winds down, we’re celebrating the innovation, collaboration, and connections that made 2024 unforgettable. Stay tuned—there’s few more to come before the year ends! ?? Looking Ahead ?? Thank you for your incredible support! We’re excited to continue driving progress, building relationships, and shaping the future of the modern lab together. Here’s to another year of success and innovation! #ThankYou #LabAutomation #LifesciencesInnovation #Community #FutureForward

    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
    • 该图片无替代文字
      +3
  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    Ganymede's case study here explores applying GxP guidelines to integrating AI in regulated environments. It highlights challenges in ensuring compliance while enhancing efficiency and decision-making in the pharmaceutical and life sciences industries. Key points include aligning AI with GxP standards, adopting a risk-based validation approach, and leveraging best practices like robust documentation and cross-functional collaboration to navigate compliance effectively. #GxP #AI #Compliance

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    ?? Join us today for our webinar "GxP and AI - Unexpected Friends in the Lab of the Future"! ?? Nathan Clark and Megan Kaveney will be exploring how AI and GxP compliance can work together to drive innovation in life sciences. ?? Happening today at 3 PM EST/12 PM PST – don’t miss out and register below! #GxP #AI #Compliance #Webinar

    查看Ganymede的公司主页,图片

    9,424 位关注者

    How can you validate your data infrastructure? On November 14th, we'll be discussing GxP and AI - both highly demanding and structured workflows that require clean data. Because of this, compliance approaches for both share a lot of unexpected similarity. Join Nathan Clark and Megan Kaveney to learn how data-driven approaches to informatics and validation are evolving in 2024. #ai #machinelearning #gxp #quality #webinar

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    ?? Powering Up Your Instrument Fleet! ?? What are the essential insights—performance metrics, downtime trends, and beyond—that keep your fleet running flawlessly? Share your secrets to success!

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    Looking forward to seeing friends and meeting new folks with life sciences data and compliance specialty at the GxP and AI webinar this Thursday. Make sure to sign up here if you're interested in this topic. We will be having an engaged discussion with attendees as well!

    查看Ganymede的公司主页,图片

    9,424 位关注者

    How can you validate your data infrastructure? On November 14th, we'll be discussing GxP and AI - both highly demanding and structured workflows that require clean data. Because of this, compliance approaches for both share a lot of unexpected similarity. Join Nathan Clark and Megan Kaveney to learn how data-driven approaches to informatics and validation are evolving in 2024. #ai #machinelearning #gxp #quality #webinar

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    ?? Choosing between building or buying instrument integration software? Why not both? In biotech, balancing customization and scalability is key. A hybrid approach—combining in-house development with third-party solutions—offers the best of both worlds. Ganymede’s flexible platform allows labs to integrate data and tailor workflows efficiently, empowering teams to innovate without being bogged down by technical limitations. This includes: 1) Hybrid Solution Advantage: A mix of building and buying software offers the flexibility of in-house solutions with the convenience of external tools, allowing labs to customize without overwhelming costs or resources. 2) Strategic Data Planning: Labs should align their data strategy with their workflow needs and automation goals, especially regarding data integration and standardization across instruments and processes. 3) Platform Flexibility: Ganymede’s platform provides an adaptable “Lab-as-Code” approach, enabling both non-coders and technical users to set up, manage, and customize data integration efficiently. #biotech #labautomation #dataintegration #futureoflabs #buildvsbuy

    Build vs Buy: Do you really have to choose when it comes to instrument integration software?

    Build vs Buy: Do you really have to choose when it comes to instrument integration software?

    Ganymede,发布于领英

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    Learn how the lab of the future can leverage a platform for AI and be GxP!

    查看Ganymede的公司主页,图片

    9,424 位关注者

    How can you validate your data infrastructure? On November 14th, we'll be discussing GxP and AI - both highly demanding and structured workflows that require clean data. Because of this, compliance approaches for both share a lot of unexpected similarity. Join Nathan Clark and Megan Kaveney to learn how data-driven approaches to informatics and validation are evolving in 2024. #ai #machinelearning #gxp #quality #webinar

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    How can you validate your data infrastructure? On November 14th, we'll be discussing GxP and AI - both highly demanding and structured workflows that require clean data. Because of this, compliance approaches for both share a lot of unexpected similarity. Join Nathan Clark and Megan Kaveney to learn how data-driven approaches to informatics and validation are evolving in 2024. #ai #machinelearning #gxp #quality #webinar

    此处无法显示此内容

    在领英 APP 中访问此内容等

  • 查看Ganymede的公司主页,图片

    9,424 位关注者

    We partnered with MasterControl to discuss how to integrate AI and robust data infrastructure within GxP (Good Practice) compliance frameworks across data integrity, explainability, and risks associated with "black-box" AI models. Things to consider as you're going through this journey: 1) Data Integrity as the Foundation: Structured, traceable data interfaces ensure that AI outputs are explainable and auditable, which is essential for compliance with GxP standards. 2) Infrastructure-as-Code (IaC) for Reliable Deployment: Using IaC frameworks, such as Terraform, helps automate infrastructure deployment while maintaining version control, making it easier to adhere to compliance requirements and support agile AI solutions. 3) Balancing Innovation with Compliance: We need to adopt AI responsibly by focusing on transparency and explainability, reducing the risks of "black-box" models and ensuring that AI enhances rather than complicates compliance efforts. Access to the full article on the MasterControl website: https://lnkd.in/eqE8w2Kz, or reach out to Ganymede to learn more about our GxP offering: https://lnkd.in/ggjCAsHS. #ai #machinelearning #gxp #quality

    • 该图片无替代文字

相似主页

查看职位

融资

Ganymede 共 2 轮

上一轮

A 轮

US$12,750,000.00

Crunchbase 上查看更多信息